Abstract
Breathing movements are initiated and controlled by a neuronal network within the lower brainstem that is influenced by peripheral and suprapontine inputs. To provide adaptation of breathing to vocalisation, exercise or hypoxia, rhythmogenic neurons of the ventral respiratory group (VRG) within the ventrolateral medulla (VLM) are controlled by numerous neuromodulators. Underlying cellular mechanisms are currently analysed in respiratory active medulla preparations from perinatal rodents. This reveals properties of the perinatal respiratory network pivotal for understanding spontaneous or drug-induced perturbation of breathing in preterm and term infants. Already at birth, ligand-gated anion channels can inhibit VLM-VRG neurons. But impairment of Cl- extrusion by hormones or growth factors may interfere with respiratory functions. During severe hypoxia, resulting in anoxia of the VLM-VRG, perinatal respiratory activity persists for more than twenty minutes, although at a greatly reduced frequency. This frequency depression, associated with a hyperpolarisation of rhythmogenic VLM-VRG neurons, is reversed by K+ channel blockers, thyrotropin-releasing hormone or substance-P, for example. This response may represent an adaptive mechanism for energy conservation during oxygen depletion. Endogenous frequency depression of the normoxic perinatal respiratory rhythm, possibly mediated by endorphins or prostaglandins, may serve to dampen excessive respiratory activity in utero. Opiates and prostaglandins, known to impair breathing in infants during clinical administration, likely act directly to depress rhythmogenic VLM-VRG neurons. Based upon such findings in perinatal rodent models on synaptic inhibition and responses to hypoxia-anoxia or clinically-applicable drugs, novel pharmacological strategies are discussed that aim to stabilise infant breathing by targeting rhythmogenic respiratory neurons.
Keywords: apnoea, anoxia, burster neurons, neuromodulation, rhythmogenesis
Current Neuropharmacology
Title: Neuromodulation of the Perinatal Respiratory Network
Volume: 2 Issue: 2
Author(s): Klaus Ballanyi
Affiliation:
Keywords: apnoea, anoxia, burster neurons, neuromodulation, rhythmogenesis
Abstract: Breathing movements are initiated and controlled by a neuronal network within the lower brainstem that is influenced by peripheral and suprapontine inputs. To provide adaptation of breathing to vocalisation, exercise or hypoxia, rhythmogenic neurons of the ventral respiratory group (VRG) within the ventrolateral medulla (VLM) are controlled by numerous neuromodulators. Underlying cellular mechanisms are currently analysed in respiratory active medulla preparations from perinatal rodents. This reveals properties of the perinatal respiratory network pivotal for understanding spontaneous or drug-induced perturbation of breathing in preterm and term infants. Already at birth, ligand-gated anion channels can inhibit VLM-VRG neurons. But impairment of Cl- extrusion by hormones or growth factors may interfere with respiratory functions. During severe hypoxia, resulting in anoxia of the VLM-VRG, perinatal respiratory activity persists for more than twenty minutes, although at a greatly reduced frequency. This frequency depression, associated with a hyperpolarisation of rhythmogenic VLM-VRG neurons, is reversed by K+ channel blockers, thyrotropin-releasing hormone or substance-P, for example. This response may represent an adaptive mechanism for energy conservation during oxygen depletion. Endogenous frequency depression of the normoxic perinatal respiratory rhythm, possibly mediated by endorphins or prostaglandins, may serve to dampen excessive respiratory activity in utero. Opiates and prostaglandins, known to impair breathing in infants during clinical administration, likely act directly to depress rhythmogenic VLM-VRG neurons. Based upon such findings in perinatal rodent models on synaptic inhibition and responses to hypoxia-anoxia or clinically-applicable drugs, novel pharmacological strategies are discussed that aim to stabilise infant breathing by targeting rhythmogenic respiratory neurons.
Export Options
About this article
Cite this article as:
Ballanyi Klaus, Neuromodulation of the Perinatal Respiratory Network, Current Neuropharmacology 2004; 2 (2) . https://dx.doi.org/10.2174/1570159043476828
DOI https://dx.doi.org/10.2174/1570159043476828 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
Call for Papers in Thematic Issues
Advances in paediatric and adult brain cancers: emerging targets and treatments
Brain tumors are the most common solid tumors affecting children and adolescents, with up to 5,000 children diagnosed per year. Pediatric brain tumors, because of their location, are often untreatable and their clinical management can cause significant long-term impairment to intellectual and neurological function with epilepsy and neurodegeneration. Other than ...read more
Emotion (dys)regulation: an integration of pharmacological, neurobiological and psychologicalframeworks
Emotion regulation is a critical aspect of mental well-being and interpersonal relationships. To fully understand and effectively address emotion regulation, an integrative approach that considers pharmacological, neurobiological, and psychological frameworks is essential. Pharmacological interventions, such as medications targeting neurotransmitter imbalances, can play a significant role in managing emotional dysregulation. Understanding ...read more
Intercellular Communications in cerebral ischemia
Cerebral ischemia, a condition in which there is inadequate blood supply to the brain, ranks as one of the leading causes of disability and mortality globally. Despite its prevalence and severity, efficacious treatment options for this debilitating disorder remain limited. Recent scientific explorations have delved deeply into the pathological mechanisms ...read more
Microbiota- Gut - Brain Axis in mood and neuropsychiatric disorders. Therapeutic opportunities
The researches of the last two decades indicate that the role of the intestinal system can be fundamental in most diseases. The bidirectional Microbiota - Gut –Brain - Axis (MGBA) includes the central nervous system (CNS), the autonomic nervous system (ANS), the vagus nerve, the neuroendocrine system, neuroimmune systems, the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies
Current Medicinal Chemistry Sodium Intake Recommendations: A Subject that Needs to be Reconsidered
Current Hypertension Reviews Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI
Current Cardiology Reviews Novel Therapeutic Targets for Diabetic Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial (Hot Topic: Drugs for Chronic Obstructive Pulmonary Disease)
Current Medicinal Chemistry Pharmacotherapy for Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Targeting Mitochondria for Cardiac Protection
Current Drug Targets Beneficial Effects of Corn Silk on Metabolic Syndrome
Current Pharmaceutical Design Pre-CKD- Do we Need Another Hero?
Current Vascular Pharmacology Diabetic Retinopathy and Atherosclerosis: is there a Link?
Current Diabetes Reviews Synthetic Glucocorticoids: Antenatal Administration and Long-term Implications
Current Pharmaceutical Design Fluoroquinolones: Blessings Or Curses
Current Drug Targets C. elegans Genetic Networks Predict Roles for O-GlcNAc Cycling in Key Signaling Pathways
Current Signal Transduction Therapy Phosphoregulation of Twist1 Provides a Mechanism of Cell Fate Control
Current Medicinal Chemistry Low-Dose Aspirin-Associated Upper and Mid Gastrointestinal Tract Damage and Gene Polymorphism
Current Pharmaceutical Design Systems Pharmacology and Pharmacokinetics Strategy to Decode Bioactive Ingredients and Molecular Mechanisms from <i>Zingiber officinale</i> as Phyto-therapeutics against Neurological Diseases
Current Drug Discovery Technologies Patterns of Interstitial Lung Disease in Egyptian Patients with Systemic Sclerosis: Relation to Disease Parameters
Current Rheumatology Reviews Impact of Sex Hormone Metabolism on the Vascular Effects of Menopausal Hormone Therapy in Cardiovascular Disease
Current Drug Metabolism Use of Contrast Echocardiography in Intensive Care and at the Emergency Room
Current Cardiology Reviews Influence of Ultrasound Mediated Transdermal Delivery of Losartan Potassium
Drug Delivery Letters